Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Neuroscience

Research Field

The Power To Change Lives

| Stephanie Sutton |

Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.

Research Field

Not Immune to Damage

| Ruth Steer |

Could activated T cells play a major role in driving neurodegeneration in glaucoma?

Research Field

Better Biomarkers for AD R&D

| Carlo Medici |

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality

Research Field

The Pitter-Patter of Tiny Diagnoses

|

A simple yet accurate model could help streamline ROP screening

Research Field

The Matchmaker

| Paul Ursell |

Introducing the easy-to-use system that offers patients lower risks of complications – regardless of surgeon experience

Research Field

Searching for Schizophrenia

| Michael Schubert |

Researchers identified the cell types associated with schizophrenia mutations

Research Field

Bringing Alzheimer’s in from the Cold

| Roisin McGuigan |

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?

Research Field

AI Picks Parkinson’s

| James Strachan |

Could artificial intelligence help repurpose old drugs for suffers of the degenerative disorder?

Research Field

Hot Off the Press

| Roisin McGuigan |

What if, instead of waiting for a donor cornea to become available, you could just print one?

Research Field

Fresher and CRISPR

|

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.


Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register